PMC:7600245 / 14604-14789 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T48","span":{"begin":15,"end":23},"obj":"Disease"},{"id":"T49","span":{"begin":27,"end":39},"obj":"Disease"}],"attributes":[{"id":"A48","pred":"mondo_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A49","pred":"mondo_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/MONDO_0020502"}],"text":"ical trial for COVID-19 or Yellow Fever in Brazil in collaboration with the U.S. NIAID (NCT03891420; n = 132) [44,45,46,47].\nThe drug is used parenterally and has demonstrated a broad-s"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T123","span":{"begin":105,"end":108},"obj":"http://purl.obolibrary.org/obo/CLO_0054061"},{"id":"T124","span":{"begin":159,"end":162},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T125","span":{"begin":176,"end":177},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"ical trial for COVID-19 or Yellow Fever in Brazil in collaboration with the U.S. NIAID (NCT03891420; n = 132) [44,45,46,47].\nThe drug is used parenterally and has demonstrated a broad-s"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T141","span":{"begin":129,"end":133},"obj":"Chemical"}],"attributes":[{"id":"A141","pred":"chebi_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"ical trial for COVID-19 or Yellow Fever in Brazil in collaboration with the U.S. NIAID (NCT03891420; n = 132) [44,45,46,47].\nThe drug is used parenterally and has demonstrated a broad-s"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T4","span":{"begin":34,"end":39},"obj":"Phenotype"}],"attributes":[{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0001945"}],"text":"ical trial for COVID-19 or Yellow Fever in Brazil in collaboration with the U.S. NIAID (NCT03891420; n = 132) [44,45,46,47].\nThe drug is used parenterally and has demonstrated a broad-s"}

{"project":"LitCovid-sentences","denotations":[{"id":"T107","span":{"begin":81,"end":124},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ical trial for COVID-19 or Yellow Fever in Brazil in collaboration with the U.S. NIAID (NCT03891420; n = 132) [44,45,46,47].\nThe drug is used parenterally and has demonstrated a broad-s"}

{"project":"LitCovid-PubTator","denotations":[{"id":"350","span":{"begin":15,"end":23},"obj":"Disease"},{"id":"351","span":{"begin":34,"end":39},"obj":"Disease"}],"attributes":[{"id":"A350","pred":"tao:has_database_id","subj":"350","obj":"MESH:C000657245"},{"id":"A351","pred":"tao:has_database_id","subj":"351","obj":"MESH:D005334"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ical trial for COVID-19 or Yellow Fever in Brazil in collaboration with the U.S. NIAID (NCT03891420; n = 132) [44,45,46,47].\nThe drug is used parenterally and has demonstrated a broad-s"}